Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients

Journal of Controlled Release

Volumn 102, Issue 1, 2005, Pages 181-190

  Perugini, Paola ^a   Hassan, Khaolé ^a   Genta, Ida ^a   Modena, Tiziana ^a   Pavanetto, Franca ^a   Cetta, Giuseppe ^a   Zanone, Chiara ^a   Iadarola, Paolo ^a   Asti, Annalia ^b   Conti, Bice ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Department of Morphological

Author keywords

Enzyme; Intracellular delivery; Liposome; Prolidase

Indexed keywords

ENZYME CARRIERS; LIPOSOME ENDOCYTOSIS; LIPOSOMES; MENTAL RETARDATION; PROLIDASE DEFICIENCY (PD); PROTEIN CARRIERS;

CELL CULTURE; CELLS; CYTOLOGY; DISEASE CONTROL; DISEASES; DRUG PRODUCTS; ENCAPSULATION; HYDRATION; PATIENT TREATMENT; THIN FILMS; TOXICITY;

ENZYMES;

DISTEAROYLPHOSPHATIDYLCHOLINE; LIPOSOME; PROLINE DIPEPTIDASE;

ARTICLE; BODY FLUID; CELL GROWTH; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; ENDOCYTOSIS; ENZYME DEFICIENCY; FIBROBLAST CULTURE; FILM; HUMAN; HUMAN CELL; HYDRATION; INCUBATION TIME; PRIORITY JOURNAL; PROLINE DIPEPTIDASE DEFICIENCY; PROTEIN LOCALIZATION; PROTEIN STABILITY; SCANNING ELECTRON MICROSCOPY; SKIN FIBROBLAST; TOXICITY;

CELLS, CULTURED; DIPEPTIDASES; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; FIBROBLASTS; HUMANS; INTRACELLULAR FLUID; LIPOSOMES;

EID: 19944428610     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.09.013     Document Type: Article

References (22)

1. A. Lavandeira Orphan drugs: legal aspects, current situation Haemophilia 8 2002 194 198
2. P. Minghetti, E.M. Giudici, and L. Montanari A proposal to improve the supply of orphan drugs Pharmacol. Res. 42 2000 33 37
3. P.E. Gregor, M.D. Jemec, T.T. April, and M.D. Moe Topical treatment of skin ulcers in prolidase deficiency Pediatr. Dermatol. 13 1996 58 60
4. C. Charpentier, K. Dagbovie, A. Lemmonier, M. Larregue, and R.A.W. Johnstone Prolidase deficiency with iminodipeptiduria: biochemical investigations and first results of attempted therapy J. Inherit. Metab. Dis. 4 1981 77 78
5. P.S. Pedersen, E. Christiansen, and N.J. Brandt Case report. Prolidase deficiency Acta Paediatr. Scand. 72 1983 785 788
6. J. Arata, K. Hatakenaka, and T. Oono Effect of topical application of glycine and proline on recalcitrant leg ulcers of prolidase deficiency Arch. Dermatol. 122 1986 626 627
7. K. Yasuda, K. Ogata, K. Kariya, H. Kodama, J. Zhang, K. Sugahara, Y. Sagara, and H. Kodama Corticosteroid treatment of prolidase deficiency skin lesions by inhibiting iminodipeptide-primed meutrophil superoxide generation Br. J. Dermatol. 141 1999 846 851
8. V. Monafo, G.L. Marseglia, M. Maghnie, K.M. Dyne, and G. Cetta Transient beneficial effect of GH replacement therapy and topical GH application on skin ulcers in a boy with prolidase deficiency Pediatr. Dermatol. 17 2000 227 230
9. G. Zanaboni, R. Grimm, K.M. Dyne, A. Rossi, G. Cetta, and P. Iadarola Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients J. Chromatogr., B, Biomed. Sci. Appl. 683 1996 97 107
10. G. Zanaboni, S. Viglio, K.M. Dyne, R. Grimm, M. Valli, G. Cetta, and P. Iadarola Direct monitoring of prolidase activity in cultured skin fibroblasts using capillary electrophoresis J. Chromatogr., B, Biomed. Sci. Appl. 695 1997 77 84
11. K. Dyne, G. Zanaboni, M. Bertazzoni, G. Cetta, S. Viglio, A. Lupi, and P. Iadarola Mild, late-onset prolidase deficiency: another Italian case Br. J. Dermatol. 144 2001 635 636
12. A. Lupi, B. Casado, M. Soli, M. Bertazzoni, L. Annovazzi, S. Viglio, G. Cetta, and P. Iadarola Therapeutic apheresis exchange in two patients with prolidase deficiency Br. J. Dermatol. 147 2002 1237 1240
13. I. Genta, P. Perugini, F. Pavanetto, K. Maculotti, T. Modena, B. Casado, A. Lupi, P. Iadarola, and B. Conti Enzyme loaded biodegradable microspheres in vitro es vivo evaluation J. Control. Release 77 2001 287 295
14. A. Lupi, P. Perugini, I. Genta, T. Modena, B. Conti, B. Casado, G. Cetta, F. Pavanetto, and P. Iadarola Biodegradable microspheres for prolidase delivery to human cultured fibroblasts J. Pharm. Pharmacol. 56 2004 597 603
15. S. Meyenburg, H. Lilie, S. Panzer, and R. Rudolph Fibrin encapsulated liposomes as protein delivery system studies on the in vitro release behavior J. Control. Release 69 2000 159 168
16. M.L. Corvo, O.C. Boerman, W.J.G. Oyen, J.C.S. Jorge, M.E.M. Cruz, D.J.A. Crommelin, and G. Storm Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model Pharm. Res. 17 2000 600 606
17. D.J. Crommelin, T. Daemen, G.L. Scherphof, M.H. Vingerhoeds, J.L.M. Heeremans, C. Kluft, and G. Storm Liposomes: vehicles for the target and controlled delivery of peptides and proteines J. Control. Release 46 1997 165 175
18. J.P. Wong, H. Yang, K.L. Blasetti, G. Schnell, J. Conely, and L.N. Schofiled Liposome delivery of ciprofloxavin against intracellular francisella tularensis infection J. Control. Release 92 2003 265 273
19. M. Grit, and D.J.A. Crommelin Determination of phosphatidylcoline, phosphatidylglycerol and their lyso forms from liposome dispersion by high-performance liquid chromatography using high-sensitivity refractive index detection J. Chromatogr. 585 1991 239 246
20. J.K. Lang Quantitative determination of cholesterol in liposome drug products and raw materials by high-performance liquid chromatography J. Chromatogr. 507 1990 157 163
21. R.L. Cleek, K.C. Ting, S.G. Eskin, and A.G. Mikos Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery J. Control. Release 48 1997 259 268
22. A. Forlino, A. Lupi, P. Vaghi, A. Icaro Cornaglia, A. Calligaro, E. Campari, and G. Cetta Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts Hum. Genet. 111 2002 314 322